Sandoz resolves patent litigation with Regeneron
Sandoz has reached an agreement with Regeneron Pharmaceuticals, Inc., to resolve all patent disputes between the two companies relating to the US Food and Drug Administration FDA-approved Sandoz aflibercept biosimilar.










